Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 14/20 | 0.53 |
| ▸ | IKZF3 | Q9UKT9 | 13/20 | 0.53 |
| ▸ | TNF | P01375 | 5/20 | 0.53 |
| ▸ | IL1B | P01584 | 3/20 | 0.53 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.53 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18975490 | 0.97 | CRBN (0.51) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL20880770 | 0.92 | CRBN (0.54) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL22694946 | 0.86 | CRBN (0.49) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL19222087 | 0.84 | CRBN (0.49) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL24243428 | 0.84 | CRBN (0.49) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL19069052 | 0.84 | POLB (0.41) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL18975485 | 0.84 | TNF (0.38) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL18976246 | 0.80 | LMNA (0.40) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL18975818 | 0.79 | CRBN (0.34) | CRBNIKZF3TNFIL1BIKZF1 | |
| SCHEMBL24137895 | 0.78 | CRBN (0.49) | CRBNIKZF3TNFIL1BIKZF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466942-B1 | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF | CELGENE CORP (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3466942-A1 | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF | Celgene Corporation (US) | 2019-04-10 | — | — | EP | disclosed |
| EP-2882736-B1 | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF | CELGENE CORP (US) | 2019-01-09 | — | — | EP | disclosed |
| US-9975872-B2 | Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof | CELGENE CORPORATION (US) | 2018-05-22 | — | — | US | disclosed |